XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Outstanding Options to Purchase Common Stock
Class A common stock
Class B common stock
Common Stock
Class A common stock
Common Stock
Class B common stock
Additional paid-in capital
Accumulated other comprehensive (loss) gain
Accumulated deficit
Balance at Dec. 31, 2022 $ 358,706       $ 12 $ 2 $ 758,366   $ (399,674)
Balance (in shares) at Dec. 31, 2022         120,006,757 19,937,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued upon exercise of stock options and vesting of restricted stock units 0                
Common stock issued upon exercise of stock options and vesting of restricted stock units (in shares)         1,552,583        
Stock-based compensation 3,908           3,908    
Net loss (23,611)               (23,611)
Balance at Mar. 31, 2023 339,003       $ 12 $ 2 762,274   (423,285)
Balance (in shares) at Mar. 31, 2023         121,559,340 19,937,500      
Balance at Dec. 31, 2022 358,706       $ 12 $ 2 758,366   (399,674)
Balance (in shares) at Dec. 31, 2022         120,006,757 19,937,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net unrealized gain (loss) on marketable securities, net of tax 0                
Foreign currency translation 0                
Net loss (49,184)                
Balance at Jun. 30, 2023 315,295       $ 12 $ 2 764,139   (448,858)
Balance (in shares) at Jun. 30, 2023         121,633,613 19,937,500      
Balance at Mar. 31, 2023 339,003       $ 12 $ 2 762,274   (423,285)
Balance (in shares) at Mar. 31, 2023         121,559,340 19,937,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued upon exercise of stock options and vesting of restricted stock units 0                
Common stock issued upon exercise of stock options and vesting of restricted stock units (in shares)         74,273        
Stock-based compensation 1,865           1,865    
Net unrealized gain (loss) on marketable securities, net of tax 0                
Foreign currency translation 0                
Net loss (25,573)               (25,573)
Balance at Jun. 30, 2023 315,295       $ 12 $ 2 764,139   (448,858)
Balance (in shares) at Jun. 30, 2023         121,633,613 19,937,500      
Balance at Dec. 31, 2023 271,619       $ 12 $ 2 767,239 $ 0 (495,634)
Balance (in shares) at Dec. 31, 2023     121,832,417 19,937,500 121,832,417 19,937,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued upon vesting of restricted stock units 0                
Common stock issued upon vesting of restricted stock units (in shares)         46,572        
Stock-based compensation 1,645           1,645    
Net unrealized gain (loss) on marketable securities, net of tax (28)             (28)  
Refund of issuance costs from 2021 Business Combination 14           14    
Foreign currency translation (5)             (5)  
Net loss (19,474)               (19,474)
Balance at Mar. 31, 2024 253,771       $ 12 $ 2 768,898 (33) (515,108)
Balance (in shares) at Mar. 31, 2024         121,878,989 19,937,500      
Balance at Dec. 31, 2023 271,619       $ 12 $ 2 767,239 0 (495,634)
Balance (in shares) at Dec. 31, 2023     121,832,417 19,937,500 121,832,417 19,937,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued upon exercise of stock options (in shares)   96,069              
Net unrealized gain (loss) on marketable securities, net of tax 0                
Foreign currency translation (7)                
Net loss (42,573)                
Balance at Jun. 30, 2024 233,260       $ 12 $ 2 771,460 (7) (538,207)
Balance (in shares) at Jun. 30, 2024     122,382,332 19,937,500 122,382,332 19,937,500      
Balance at Mar. 31, 2024 253,771       $ 12 $ 2 768,898 (33) (515,108)
Balance (in shares) at Mar. 31, 2024         121,878,989 19,937,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Common stock issued upon vesting of restricted stock units 0                
Common stock issued upon vesting of restricted stock units (in shares)         407,274        
Common stock issued upon exercise of stock options 136           136    
Common stock issued upon exercise of stock options (in shares)         96,069        
Stock-based compensation 2,426           2,426    
Net unrealized gain (loss) on marketable securities, net of tax 28             28  
Foreign currency translation (2)             (2)  
Net loss (23,099)               (23,099)
Balance at Jun. 30, 2024 $ 233,260       $ 12 $ 2 $ 771,460 $ (7) $ (538,207)
Balance (in shares) at Jun. 30, 2024     122,382,332 19,937,500 122,382,332 19,937,500